# ZNF433

## Overview
ZNF433 is a gene that encodes the zinc finger protein 433, a member of the KRAB zinc-finger protein family, which is characterized by the presence of C2H2 zinc finger domains and a KRAB domain. These structural features enable the protein to function primarily as a transcription factor, binding to specific DNA sequences to regulate gene expression. Zinc finger protein 433 is involved in various cellular processes, including cell differentiation, development, and cellular metabolism, by modulating transcriptional activities within the nucleus (Heyliger2021The). The protein's interaction with the beta-catenin/TCF signaling pathway highlights its role in promoting cell proliferation and motility, which are essential for normal cellular functions and development (p&gt; ZNF433; Gu2019&lt). ZNF433 has clinical significance in several diseases, including clear-cell renal cell carcinoma and prostate cancer, where its expression levels and interactions are altered, suggesting its potential as a therapeutic target (Heyliger2021The; p&gt; ZNF433; Gu2019&lt).

## Structure
ZNF433 is a member of the KRAB zinc-finger protein family, characterized by the presence of C2H2 zinc finger domains and a KRAB domain. These domains are involved in DNA binding and transcriptional regulation. The C2H2 motif typically consists of two cysteine and two histidine residues that coordinate a zinc ion, forming a stable structure that facilitates DNA interaction. The KRAB domain, located at the N-terminus, is known for its role in transcriptional repression and epigenetic regulation (Heyliger2021The).

The protein structure of ZNF433 includes variations in amino acid sequences that may allow it to bind multiple ligands, indicating a potential for diverse regulatory functions. These structural variations are common among KRAB-ZNF proteins, which are often tissue-specific and act as transcriptional repressors (Heyliger2021The).

Post-translational modifications, such as methylation of the promoter region, have been observed in ZNF433, correlating with mRNA suppression in certain cancers, such as clear-cell renal cell carcinoma (ccRCC) (Heyliger2021The). However, specific details about the secondary, tertiary, or quaternary structures of ZNF433 are not provided in the available literature.

## Function
ZNF433, a zinc finger protein, functions primarily as a transcription factor in healthy human cells. It is characterized by zinc finger motifs that enable it to bind to specific DNA sequences, thereby regulating the expression of target genes. This protein is involved in various cellular processes, including cell differentiation and development, by modulating the transcriptional landscape within the nucleus, where it is predominantly active (Heyliger2021The).

In the context of cellular metabolism, ZNF433 has been implicated in influencing cellular energetics and mitochondrial function. It is associated with pathways related to cellular metabolism, particularly those involved in cellular processes and protein transport (Heyliger2021The). The protein's activity in these pathways suggests a role in maintaining cellular homeostasis and energy balance.

ZNF433's involvement in the beta-catenin/TCF signaling pathway has also been noted, where it acts as a binding partner to beta-catenin, enhancing this pathway's activity. This interaction is crucial for promoting cell proliferation and motility, which are essential for normal cellular functions and development (p&gt; ZNF433; Gu2019&lt). The protein's regulatory functions underscore its importance in maintaining normal cellular and organismal physiology.

## Clinical Significance
ZNF433 has been implicated in several diseases due to alterations in its expression levels and interactions. In clear-cell renal cell carcinoma (ccRCC), ZNF433 is significantly downregulated, particularly in higher stages and grades of the disease. This downregulation is associated with poorer clinical outcomes and reduced patient survival, suggesting that ZNF433 may function as a tumor-suppressor gene in this context. The suppression of ZNF433 in ccRCC is thought to be influenced by epigenetic mechanisms, such as hypermethylation of its promoter region, and mutations in genes involved in chromatin remodeling, including BAP1, SETD2, and KDM5C (Heyliger2021The).

In prostate cancer, ZNF433 is upregulated, promoting cancer cell growth and migration. This upregulation is linked to the activation of the beta-catenin/TCF signaling pathway, which is crucial for tumorigenic behaviors in prostate cancer cells. The interaction between ZNF433 and beta-catenin enhances this pathway, suggesting a role for ZNF433 as a potential therapeutic target in prostate cancer (p&gt; ZNF433; Gu2019&lt).

Additionally, ZNF433 has been suggested as a susceptibility gene for multiple sclerosis, with certain SNPs in the gene showing a suggestive association with the disease (Nischwitz2010Evidence).

## Interactions
ZNF433, a zinc finger protein, is known to interact with the beta-catenin/TCF signaling pathway in prostate cancer. It acts as a binding partner to beta-catenin, facilitating the activation of the beta-catenin/TCF pathway. This interaction enhances the binding between beta-catenin and TCF4, which is crucial for the transcriptional activation of target genes involved in cancer progression (p&gt; ZNF433; Gu2019&lt). The study by Gu et al. utilized immunoprecipitation assays to evaluate the binding between ZNF433 and beta-catenin, demonstrating the physical interaction between these proteins (p&gt; ZNF433; Gu2019&lt).

In the context of clear-cell renal cell carcinoma (ccRCC), ZNF433 is implicated in cellular metabolic processes and immune function, although specific protein interactions in this context are not detailed (Heyliger2021The). The gene is part of the KRAB-ZNF protein family, which often functions as transcription factors, suggesting potential interactions with DNA or other proteins to regulate gene expression (Heyliger2021The). However, detailed interactions of ZNF433 in ccRCC or other conditions remain to be fully elucidated.


## References


[1. (Heyliger2021The) Simone O. Heyliger, Karam F. A. Soliman, Marilyn D. Saulsbury, and Romonia Renee Reams. The identification of zinc-finger protein 433 as a possible prognostic biomarker for clear-cell renal cell carcinoma. Biomolecules, 11(8):1193, August 2021. URL: http://dx.doi.org/10.3390/biom11081193, doi:10.3390/biom11081193. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom11081193)

[2. (Nischwitz2010Evidence) Sandra Nischwitz, Sabine Cepok, Antje Kroner, Christiane Wolf, Matthias Knop, Felix Müller-Sarnowski, Hildegard Pfister, Darina Roeske, Peter Rieckmann, Bernhard Hemmer, Marcus Ising, Manfred Uhr, Thomas Bettecken, Florian Holsboer, Bertram Müller-Myhsok, and Frank Weber. Evidence for vav2 and znf433 as susceptibility genes for multiple sclerosis. Journal of Neuroimmunology, 227(1–2):162–166, October 2010. URL: http://dx.doi.org/10.1016/j.jneuroim.2010.06.003, doi:10.1016/j.jneuroim.2010.06.003. This article has 61 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jneuroim.2010.06.003)